about
Recurrent aseptic meningitis associated with amoxicillin-clavulanic acidPartial motor status epilepticus as a clinical manifestation of carotid stenosis.Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment.Recommendations and treatment strategies for the management of acute ischemic stroke.Oral anticoagulation in elderly patients as secondary prevention of cardioembolic strokesAcute cervical artery dissection after a dental procedure due to a second inferior molar infectionDilemma in the emergency setting: hypomagnesemia mimicking acute stroke.Stroke pathophysiology: management challenges and new treatment advances.Clinical practice guidelines in intracerebral haemorrhage.Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type.Guidelines for the treatment of acute ischaemic stroke.Long term evolution of patients treated in a TIA unit.Code stroke in Asturias.Safety and Efficacy of Mechanical Thrombectomy in Acute Ischemic Stroke of Anticoagulated Patients-A Prospective Observational Study.Recurrent confusional episodes associated with hypomagnesaemia due to esomeprazol.Chronic migraine does not increase posterior circulation territory (PCT) infarct-like lesions.[Ultrasound measurement of carotid stenosis: recommendations from the Spanish Society of Neurosonology].Atrial fibrillation in cryptogenic stroke: new tools needed for diagnosis?[Ring chromosome 20: a distinctive syndrome identifiable by electroclinical diagnosis]Vitamin K antagonist-associated intracerebral hemorrhage: lessons from a devastating disease in the dawn of the new oral anticoagulants.Symptomatic intracerebral hemorrhage and recanalization after IV rt-PA: a multicenter study.Health care resources for stroke patients in Spain, 2010: analysis of a national survey by the Cerebrovascular Diseases Study Group.Headache as a crucial symptom in the etiology of convexal subarachnoid hemorrhage.Analysis of the new code stroke protocol in Asturias after one year. Experience at one hospital.Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke.Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style.Teaching neuroimages: carotid body tumor as a novel cause of cerebral ischemic stroke.Thrombolysis in patients with stroke and marked clinical fluctuations.Antiphospholipid Syndrome of Late Onset: A Difficult Diagnosis of a Recurrent Embolic Stroke.[Analysis of the direct costs associated with mechanical thrombectomy and intravenous fibrinolysis in the Hospital Universitario Central de Asturias].Vasomotor reactivity is similarly impaired in patients with Alzheimer's disease and patients with amyloid hemorrhage.Convexity subarachnoid haemorrhage secondary to internal carotid stenosis: an indication for revascularisation.[Reflex epilepsies][Stroke units: the best treatment for stroke patients].Recurrent lacunar ischaemic stroke due to resistance to antiplatelet treatment: examining the need for personalised antithrombotic therapy.Code stroke. Can we improve stroke times? A reply.Infrequent presentation of giant cell arteritis.High prevalence of right to left shunt in women with chronic migraine.Derivation of Transcranial Doppler Criteria for Rescue Intra-arterial ThrombolysisCluster-like headache heralding cerebral venous thrombosis
P50
Q28372284-3FA96ACA-9476-4616-A29C-8A70CD548A75Q30496660-9781AA45-54BE-4DCF-96DC-A6F7283FF5B5Q30572460-A8B9BDC6-3300-4739-AD92-9FC766400DD5Q31153077-4537F221-4137-4215-A35A-8789D848FB52Q33933527-4CCA5A74-954B-4340-8004-048D406607F5Q35698351-489BB4B4-0CFC-4D0D-9B11-E29CF5445F62Q37012172-B63698D6-DFDA-485A-B1CE-7836FD4804C0Q37098053-903A48C1-B06E-4EC6-AB76-FDB51BA0976AQ37875439-116996FA-2865-44B2-9F6F-FD2CA539D6BCQ37936617-019B0253-EEDE-48A1-A7CB-3F4F1E01E645Q37966157-5B150C6D-96B9-45D9-8727-4C37AD9BA832Q38103322-ED3D5DC8-9776-4649-BB68-7D0F110543D5Q38386632-FCFFE506-B989-4945-97D3-ECAD579BCC21Q39631593-1E5FEE71-BC2E-4FDD-A58D-44504004571DQ42286561-279A0263-DA60-443C-B289-649E840CD2C6Q43490750-18D31329-66D7-413B-B0A9-F1C8657C560DQ43694555-50EFB1E5-E4A6-41AB-A06B-910835E2316DQ44760151-BD93AF42-2CCA-4FED-95F4-2EA2D4E45ED7Q44887052-12BFE6AC-E965-45F8-B49D-F13F6A143AB1Q44928416-251F2643-BD40-43E1-B43B-3A120C942DD4Q46406889-FCC6B738-EC79-4CE5-84CF-6AB029B2E5FAQ46644383-9E02BEE3-D9FE-4465-A15C-E4D38F6C9CD5Q46848722-0BA8ECB0-B5A9-43BD-A346-43C1F6899AACQ47729366-D2181D7E-631C-43D9-91FB-56F919AC80A0Q48278361-F2CCB4F6-E20F-415A-9C07-935771679AAEQ48284695-8B66ACFE-A7E1-457F-A26E-37F2C5885F03Q48417610-3276AA9B-782A-47D6-8CA8-B4E1AA8C5FD6Q48710929-B1F250A4-D0AD-49C8-8146-01ACFBDDEE4FQ49065917-3F7F599F-3990-446E-950B-6B24A7895E5DQ49687271-4880962D-DE9F-497D-A9DA-CE1B2539C4DAQ53305806-64E8AC8D-D1C7-4470-88CA-C72BD6628E0EQ53914369-6D9119EF-063A-4A1F-A012-C18B3BC15EFFQ54043695-C694872A-D87C-4B39-8688-ACDE31E6D987Q54397599-00EFF760-3260-4E5C-8CA9-4BD8CD58A2E6Q54448866-D688C707-C4FA-42B8-A8EF-FBB466B4A44FQ54714318-25A4B818-3C8D-425B-A29E-62CE8B114500Q54911496-82C30675-0BB0-4FA9-BF07-819F4FBF889FQ55156682-F0624EC8-0124-4C69-9E04-CC4669088973Q57756981-54B951B8-B0D1-46E2-8D9F-97E938C64E3DQ64044717-B8466C60-6028-4E9A-AD5D-9E83A0E79ACA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sergio Calleja
@ast
Sergio Calleja
@en
Sergio Calleja
@es
Sergio Calleja
@nl
Sergio Calleja
@sl
type
label
Sergio Calleja
@ast
Sergio Calleja
@en
Sergio Calleja
@es
Sergio Calleja
@nl
Sergio Calleja
@sl
prefLabel
Sergio Calleja
@ast
Sergio Calleja
@en
Sergio Calleja
@es
Sergio Calleja
@nl
Sergio Calleja
@sl
P106
P1153
6701801004
P21
P31
P496
0000-0002-9050-6771